Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe - Author's reply.
Options
BORIS DOI
Publisher DOI
PubMed ID
38901496
Date of Publication
2024-09
Publication Type
Article
Subject(s)
Language(s)
en
Contributor(s)
Lange, Christoph | |
Kherabi, Yousra | |
Guglielmetti, Lorenzo | |
Duarte, Raquel |
Additional Credits
Series
Clinical microbiology and infection
Publisher
Elsevier
ISSN
1469-0691
Access(Rights)
embargo